Xu ML - Search Results

1

Microenvironment Cell Contribution to Lymphoma Immunity.

Kumar D, Xu ML. Kumar D, et al. Among authors: xu ml. Front Oncol. 2018 Jul 27;8:288. doi: 10.3389/fonc.2018.00288. eCollection 2018. Front Oncol. 2018. PMID: 30101129 Free PMC article. Review.

2

Lymphoma Microenvironment and Immunotherapy.

Xu ML, Fedoriw Y. Xu ML, et al. Surg Pathol Clin. 2016 Mar;9(1):93-100. doi: 10.1016/j.path.2015.10.001. Surg Pathol Clin. 2016. PMID: 26940270 Review.

3

Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity.

Kumar D, Xu ML. Kumar D, et al. Among authors: xu ml. Front Oncol. 2018 Nov 8;8:522. doi: 10.3389/fonc.2018.00522. eCollection 2018. Front Oncol. 2018. PMID: 30460201 Free PMC article.

4

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis.

Li P, Yuan J, Ahmed FS, McHenry A, Fu K, Yu G, Cheng H, Xu ML, Rimm DL, Pan Z. Li P, et al. Among authors: xu ml. Front Oncol. 2021 Aug 30;11:701492. doi: 10.3389/fonc.2021.701492. eCollection 2021. Front Oncol. 2021. PMID: 34527580 Free PMC article.

5

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases.

Li P, Biancon G, Patel T, Pan Z, Kothari S, Halene S, Prebet T, Xu ML. Li P, et al. Among authors: xu ml. Front Oncol. 2021 Sep 13;11:730503. doi: 10.3389/fonc.2021.730503. eCollection 2021. Front Oncol. 2021. PMID: 34589432 Free PMC article.

6

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.

Jawad M, Afkhami M, Ding Y, Zhang X, Li P, Young K, Xu ML, Cui W, Zhao Y, Halene S, Al-Kali A, Viswanatha D, Chen D, He R, Zheng G. Jawad M, et al. Among authors: xu ml. Front Oncol. 2022 Feb 28;12:849376. doi: 10.3389/fonc.2022.849376. eCollection 2022. Front Oncol. 2022. PMID: 35296003 Free PMC article.

7

Benign lymph node microenvironment is associated with response to immunotherapy.

Toki MI, Kumar D, Ahmed FS, Rimm DL, Xu ML. Toki MI, et al. Among authors: xu ml. Precis Clin Med. 2020 Mar;3(1):44-53. doi: 10.1093/pcmedi/pbaa003. Epub 2020 Feb 12. Precis Clin Med. 2020. PMID: 35693430 Free PMC article.

8

Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.

Pelland K, Mathews S, Kamath A, Cohen P, Hudnall SD, Cotta CV, Xu ML. Pelland K, et al. Among authors: xu ml. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):e101-e106. doi: 10.1097/PAI.0000000000000615. Appl Immunohistochem Mol Morphol. 2018. PMID: 29189264

9

Small Cell Variant of Intravascular Large B-Cell Lymphoma: Highlighting a Potentially Fatal and Easily Missed Diagnosis.

Rahmani M, Halene S, Xu ML. Rahmani M, et al. Among authors: xu ml. Biomed Res Int. 2018 Apr 3;2018:9413015. doi: 10.1155/2018/9413015. eCollection 2018. Biomed Res Int. 2018. PMID: 29850589 Free PMC article.

10

Angioimmunoblastic T-cell lymphoma: Current Diagnostic Insights and Advances.

Matsumoto NP, Xu ML. Matsumoto NP, et al. Among authors: xu ml. Hum Pathol. 2024 Nov 19:105696. doi: 10.1016/j.humpath.2024.105696. Online ahead of print. Hum Pathol. 2024. PMID: 39571692 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters